Smart science to improve lives™

Super Refined™ excipients for oral drug delivey - CP22

Oral drug development of both new and existing chemical entities often face numerous challenges including poor solubility, formulation instability and ineffective drug delivery. Regardless of the challenge, the ultimate goal is to create successful drug products with shortened development timelines. The selection of the right oral excipient during early phase development is critical to achieve this goal.


POS (英語)

言語: 英語

フォーマット: PDF

ファイルサイズ: 1.8 MB